SEC Form 4 · accession 0001179110-15-014474

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP Commercial Ops

Period of report

Nov 2, 2015

Accepted (ET)

Nov 4, 2015 · 4:27 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 2, 2015	M	184	$26.99	D	48,967	D
Common Stock	Nov 2, 2015	M	1,816	$40.56	D	50,783	D
Common Stock^F4	Nov 2, 2015	S	2,000	$108.356	D	48,783	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$26.99	Nov 2, 2015	M	184	D	—	Jul 30, 2018	Common Stock	184	2,823	D
Non-Qualified Stock Option (right to buy)^F3	$40.56	Nov 2, 2015	M	1,816	D	—	Feb 1, 2023	Common Stock	1,816	10,255	D

F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4Sale prices reported for the transactions reported here range from $108.33 to $108.42. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.